US$ 25.99
glp-1 blindness GLP 1 Risk The protective role of GLP-1
Description
n = 88 of 4,672 patients, respectively

Breastfeeding should not hurt

Evidence-based recommendations are critical to ensure the safe and efficient use of these medications in the treatment of obesity as their use continues to increase

In this study, once-weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, or 15 mg) were compared to once-daily subcutaneous injections of titrated insulin degludec
Gone are the days of a one-size-fits-all solution to overall wellness

Hazard ratios (HR) were adjusted for confounders, providing a robust estimate of associations